InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
17,060.40
(
0.00%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.29
(
0.07%
)
Bitcoin
64,093.86
(
-0.29%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 181659

Tuesday, 10/28/2014 9:11:42 AM

Tuesday, October 28, 2014 9:11:42 AM

Post# of 251590
SNY -8% PM* on forecast of flat diabetes sales in 2015:

http://www.thestreet.com/story/12929731/1/sanofi-sny-stock-drops-today-as-diabetes-sales-expected-to-be-flat-in-2015.html

Chief Executive Officer Chris Viehbacher said the drugmaker cut prices for its best-selling product, Lantus, last quarter to get on U.S. drug benefit managers' reimbursement lists in the face of competition from companies including Novo Nordisk…

Lantus has become the “next Advair” wrt pushback from payers.

*Trading lower in European home market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up